MML Investors Services LLC Trims Stock Position in Encompass Health Co. (NYSE:EHC)

MML Investors Services LLC lowered its stake in shares of Encompass Health Co. (NYSE:EHC) by 3.9% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 18,327 shares of the company’s stock after selling 737 shares during the period. MML Investors Services LLC’s holdings in Encompass Health were worth $1,771,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of EHC. Point72 Asset Management L.P. raised its stake in shares of Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after buying an additional 835,135 shares during the last quarter. Magnetar Financial LLC raised its stake in shares of Encompass Health by 1,176.6% during the 2nd quarter. Magnetar Financial LLC now owns 744,836 shares of the company’s stock valued at $63,899,000 after buying an additional 814,018 shares during the last quarter. Thrivent Financial for Lutherans raised its stake in shares of Encompass Health by 2,302.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 603,558 shares of the company’s stock valued at $51,780,000 after buying an additional 578,438 shares during the last quarter. AQR Capital Management LLC raised its stake in shares of Encompass Health by 213.3% during the 2nd quarter. AQR Capital Management LLC now owns 207,202 shares of the company’s stock valued at $17,776,000 after buying an additional 141,075 shares during the last quarter. Finally, Cubist Systematic Strategies LLC raised its stake in shares of Encompass Health by 762.4% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 83,347 shares of the company’s stock valued at $7,150,000 after buying an additional 73,683 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Truist Financial restated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. UBS Group lifted their price target on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. KeyCorp lifted their price target on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Royal Bank of Canada lifted their price target on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, Barclays lifted their price target on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $107.11.

Encompass Health Price Performance

NYSE:EHC opened at $96.94 on Wednesday. Encompass Health Co. has a 12 month low of $65.39 and a 12 month high of $104.55. The stock has a 50 day moving average of $99.49 and a two-hundred day moving average of $92.77. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market cap of $9.77 billion, a P/E ratio of 23.42, a price-to-earnings-growth ratio of 1.34 and a beta of 0.86.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.86 EPS. On average, analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio is currently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.